Extracellular matrix aggregates comprising the proteoglycan versican and glycosaminoglycan hyaluronan are necessary for cardiac development. Here we identify failure of primary vascular plexus formation and attenuation of primitive hematopoiesis in the yolk sac of the mouse insertional mutant Vcan hdf , which lacks all versican isoforms. Spatially co-regulated versican and hyaluronan were intimately associated with Flk1+ hematovascular progenitor cells migrating from the primitive streak into extraembryonic mesoderm, although not with the differentiated successors. In the absence of versican, yolk sac and embryo hyaluronan were severely depleted, suggesting that versican stabilizes extracellular hyaluronan. Vcan inactivation by CRISPR/Cas9 in mouse embryonic stem cells reduced expression of vascular endothelial and hematopoiesis markers in embryoid bodies, which formed fewer and shorter vascular sprouts in response to VEGF 165 and fewer blood colonies. These findings, together with single-cell transcriptome data, suggest that versican-hyaluronan pericellular matrix provides a crucial niche for hematovascular progenitors immediately after their genesis at gastrulation.
Introduction
The first blood vessels in amniotes form de novo in the yolk sac prior to initiation of hemodynamic forces, indicating an in situ differentiation driven by their local environment, which includes extracellular matrix (ECM). This vasculogenic process is inextricably linked to primitive hematopoiesis, i.e., formation of the first erythroid and myeloid cells (Risau and Flamme, 1995) , implying a close lineage relationship or continuum between vascular endothelium and primitive eythropoiesis. The necessary progenitor cells arise from mesoderm at gastrulation, migrate from the primitive streak, and aggregate in blood islands in the proximal extra-embryonic yolk sac on the seventh day of gestation (E7) in mouse embryos (Dzierzak and Speck, 2008; Ferkowicz and Yoder, 2005) . Several transcription factors and soluble effectors of vasculogenesis and hematopoiesis have been identified; although ECM and products of ECM turnover are known as major regulators of angiogenesis (Red-Horse et al., 2007) , their effect on the first endothelial cells formed, the precursors of those cells and early hematopoietic cells is as yet undetermined.
Primordial germ cells, which migrate to the extraembryonic allantois, are accompanied by a protective "traveling niche" of steel factor/stem cell factor producing cells during their journey to the gonads (Gu et al., 2009) . Whether an ECM niche such as a pericellular matrix surrounds or accompanies developing and migrating hematovascular progenitor cells is unknown.
ECM surrounds all mammalian cells, other than circulating blood cells, forming a distinct pericellular matrix in some cell types, as well as an interstitial matrix. It regulates cell behavior by modulating cell adhesion, migration and tissue mechanics, sequesters growth factors and cytokines, and is a source of bioactive fragments. Proteoglycans, which are composite ECM and cell-surface molecules with one or more glycosaminoglycan chains covalently attached to a core protein, participate in all these mechanisms. For example, chondroitin sulfate proteoglycans (CSPGs) such as versican, which are bulky and inherently anti-adhesive, regulate focal adhesion formation and inhibit cell migration (Mead et al., 2018; Perris et al., 1996; Yamagata et al., 1989) . Heparan sulfate proteoglycans (HSPGs) sequester growth factors, including angiogenic growth factors such as VEGF-A and FGF2 through heparan sulfate (HS) chains and act as co receptors for angiogenic signaling (van Wijk and van Kuppevelt, 2014) . Although CSPGs can bind VEGF and functionally overlap with HSPGs in VEGF-induced sprouting angiogenesis (Le Jan et al., 2012) , a physiological context for their VEGF-regulating activity has yet to be uncovered.
Versican is a widely distributed CSPG that aggregates with the glycosaminoglycan hyaluronan (HA), through its N-terminal G1 domain (Bode-Lesniewska et al., 1996; Kimata et al., 1986; Shinomura et al., 1993; Zimmermann and Ruoslahti, 1989) . Its C-terminal G3 domain binds to ECM components fibronectin, fibrillins and tenascins (Wu et al., 2005) as well as VEGF-A (Zheng et al., 2004) . Through interaction of HA with cell-surface receptors such as CD44, versican is a major component of pericellular matrix, where it regulates cell adhesion and consequently, contractile cytoskeleton assembly, and is postulated to influence cell differentiation through this mechanism (Hattori et al., 2011; Mead et al., 2018; Nandadasa et al., 2015) . Four versican isoforms (V0, V1-V3) arise from alternative splicing of large exons, numbered 7 and 8, that encode the CS-bearing domains, named GAGα and GAGβ respectively (Dours-Zimmermann and Zimmermann, 1994; Shinomura et al., 1993) . The versican insertional mutant mouse allele (Vcan Hdf ), which lacks all isoforms, identified an essential role for versican in early cardiac development (Mjaatvedt et al., 1998; Yamamura et al., 1997) . Like Vcan Hdf/Hdf embryos, Has2 null embryos, lacking the major HA synthase die by 10.5 days of gestation with similar cardiac defects (Camenisch et al., 2000) , demonstrating that the versican-HA complex is a major constituent of cardiac jelly. Here, upon identification of an abnormal vasculature in Vcan Hdf/Hdf yolk sac, we investigated its role in vasculogenesis and early hematopoiesis. The analysis demonstrated intimate association of versican and HA with Flk1+ hematoendothelial progenitor cells from their origin at gastrulation, demonstrated that versican was necessary for retaining HA in embryonic ECM, and indicated a vital role for the versican-HA pericellular matrix in determining Flk1+ progenitor fate.
Results

Vcan Hdf/Hdf yolk sacs lack a vascular plexus:
Vcan Hdf/Hdf embryos did not survive past E10.5, and were readily distinguished at E9.5 by their small size and dilated pericardial sac ( Fig. 1A) . Although major developmental milestones, including chorio-allantoic fusion, neural pore closure, axial rotation of the embryo, formation of branchial arches and initiation of cardiac contraction, were completed appropriately by E9.5, Vcan Hdf/Hdf yolk sacs and embryos appeared substantially less vascular ( Fig. 1B,C) . Whole mount CD31 immunostaining revealed the absence of a vascular network in E9.5 Vcan Hdf/Hdf yolk sacs contrasting with a well-branched network in the wild type yolk sac. Instead, unorganized, scattered vascular endothelial cells were evident in Vcan Hdf/Hdf yolk sacs (Fig. 1C ).
Immunostaining of E9.5 wild type yolk sac localized versican to ECM of yolk sac mesoderm where it surrounded the vasculature, whereas no staining was seen in wild-type visceral endoderm and Vcan Hdf/Hdf yolk sacs ( Fig. 1D ). Intriguingly, staining with hyaluronan binding protein (HAbp), which showed overlapping distribution of HA and versican in wild type yolk sac mesoderm, identified an unexpected loss of HA staining in Vcan Hdf/Hdf yolk sacs ( Fig.   1D ). Fibronectin immunostaining in contrast, showed increased staining in Vcan Hdf/Hdf yolk sacs, whereas collagen IV staining was unaffected ( Fig. 1D ), suggesting that loss of HA was not a consequence of global ECM reduction in the Vcan Hdf/Hdf yolk sacs. Similar to other mouse mutants lacking yolk sac vasculogenesis and hematopoiesis including Has2, Itga5 and Fn1-null alleles (Camenisch et al., 2000; Francis et al., 2002) , Vcan Hdf/Hdf yolk sacs consistently showed detachment of the mesoderm from visceral endoderm and few blood islands or blood cells were observed ( Fig 1D, Fig. S2 A-C). They also consistently showed more intense endoderm F-actin staining compared to the wild type ( Fig. 1 D, Fig. S2A ), and rounded, rather than spindleshaped nuclei in yolk sac mesothelium ( Fig. S2B ). Transmission electron microscopy (TEM), using a method that preserves cell-matrix interactions (Hunziker et al., 1983) showed complete coverage of blood islands with vascular endothelium in wild type yolk sac and detached vascular endothelial cells with numerous membrane protrusions in Vcan Hdf/Hdf yolk sacs ( Fig.   S2C ). Thus, versican is essential for proper yolk sac morphogenesis and function.
We traced the chronology of yolk sac development retrospectively to determine the genesis of yolk sac avascularity. In contrast to E9.5 embryos, E8.5 Vcan Hdf/Hdf embryos were developmentally indistinguishable from wild type embryos, although they appeared pale and their yolk sacs lacked a visible vascular network ( Fig. 2B ). CD31 immunostaining of whole mount E8.5 embryos identified severe, widespread attenuation of vasculature ( Fig. 2B ). In wild type yolk sac, en face CD31 staining demonstrated a honeycomb-like plexus, which was absent in Vcan Hdf/Hdf yolk sacs ( Fig. 2C ). Intriguingly, immunostaining of versican and CD31, together with HA-staining in E8.5 wild type yolk sacs revealed that versican and HA consistently colocalized in patches corresponding to individual endothelial cells on the mesothelial aspect of blood islands (Fig. 2D ). RNA in situ hybridization with Vcan exon 7 (GAG α), or exon 8 (GAG β)specific probes revealed that only the exon 8 probe hybridized to E8.5 yolk sac mesoderm ( Fig   2E) , suggesting prevalence of the versican V1 isoform at this developmental stage. In contrast, both Vcan probes hybridized strongly to E8.5 wild type hearts ( Fig. 2F ) and did not hybridize to Vcan Hdf/Hdf hearts (e.g., exon 8 probe, Fig. 2G ), indicative of their specificity.
Versican and HA surround Flk1+ progenitor cells
Since Vcan Hdf/Hdf yolk sacs and embryos had defective vasculogenesis and few blood cells, we investigated the relationship between versican patches in the blood islands and hematovascular progenitor cells. Flk1, a well characterized hemo-endothelial progenitor marker, indispensable for both vascular and blood lineage development (Shalaby et al., 1997) showed complete overlap with versican and hyaluronan on the mesothelial aspect of blood islands in wild type E8.5 yolk sac (Fig. 3A) . Vcan Hdf/Hdf yolk sacs, in contrast, showed small blood islands with dramatically attenuated HA and Flk1 staining (Fig. 3A) . En face confocal microscopy of dissected E8.5 whole mount yolk sacs revealed discrete patches of versican distributed throughout the mesoderm (Fig. 3B ). CD41, which is expressed upon specific commitment to the blood lineage (Ferkowicz et al., 2003) , was strongly expressed in blood islands in the midmesoderm plane in wild type yolk sacs ( Fig. 3B ). Versican did not colocalize with CD41+ cells and was restricted to intense patches corresponding to individual endothelial cells in wild type yolk sacs, evident both in the surface (mesothelial) plane and cross sections and Vcan Hdf/Hdf yolk sacs lacked CD41-stained blood islands entirely ( Fig. 3B ). High magnification images show a few cells with weak CD41 staining in Vcan Hdf/Hdf yolk sac mesoderm (arrowheads in Fig. 3B ), contrasting with well-demarcated CD41+ wild-type blood islands. Combined, these results show that versican and HA distribution at E8.5 is restricted and specific to uncommitted Flk1+ hemogenic endothelial cells, which are crucial for both blood and vascular development in the mouse embryo. However versican and HA are not associated with blood cells through subsequent differentiation ( Fig. 3B,C) .
Methylcellulose colony formation assays demonstrated fewer colony-forming units (CFUs) in E8.5 Vcan Hdf/Hdf embryos and yolk sacs ( Fig. 3D ), in agreement with fewer CD41stained blood islands observed in the yolk sac. Similarly, qRT-PCR revealed significantly lower Flk1 expression in Vcan Hdf/Hdf yolk sac and embryos ( Fig. 3E ), in agreement with reduced Flk1 staining observed in situ in the mutant (Fig. 3A ). Neither expression of Has2, encoding the major HA synthase in the embryo, nor of Brachyury, a mesoderm marker, were altered in Vcan Hdf/Hdf yolk sacs or embryos ( Fig. 3F ). Expression of genes encoding blood lineage commitment markers Itga2b (CD41) and Runx1 were similarly reduced in the Vcan Hdf/Hdf yolk sacs and embryos ( Fig. 3G ), as well as erythroid and myeloid transcripts Hbb (β-globin), Gata1
and Ptprc (CD45) ( Fig. 3H ). CD31 (Pecam1) mRNA expression was greatly reduced in the Vcan Hdf/Hdf yolk sacs and embryos ( Fig. 3I) , consistent with the observed lack of vasculature ( Fig. 2B ). These data suggested that lack of the versican-HA resulted in impaired blood and vascular differentiation.
Versican and HA are associated with Flk1 cells at gastrulation
Since Flk1+ cells arise at gastrulation, we analyzed versican and HA localization in wild type E7.5 mouse embryos. Strikingly, versican staining of whole mount E7.5 embryos revealed ringlike distribution in the proximal extraembryonic region coinciding with the expected location of the blood island ring (Fig. 4A) . Sections from these embryos demonstrated versican and HA colocalization in the extraembryonic mesoderm in the blood island region (Fig. 4B ). Confocal microscopy revealed that the versican-HA patches corresponded to the location of Flk1+ mesodermal progenitor cells ( Fig. 4C,D) . RNA In situ hybridization of serial sections from several embryos showed considerable overlap between Vcan exons 7 and 8, Has2 and Flk1 expressing cells in extraembryonic mesoderm and embryonic mesoderm ( Fig. 4E, Fig. S3 ).
Vcan exon 7-containing transcripts showed less intense expression than exon 8 probes in the blood island ring, although they were detected. Runx1, which specifically defines blood lineagecommitted cells, was expressed by cells in a region of proximal extraembryonic mesoderm distinct from that expressing Flk1, Vcan and Has2 (Fig. 4E, Fig. S3 ). Thus, these data localize versican and HA to a hematovascular compartment defined by Flk1+ cells and suggest that a versican-HA ECM is intimately associated with and a defining characteristic of Flk1+ cells.
Data mining of a recently published single cell RNA sequencing (scRNAseq) analysis of the early mouse embryo spanning gestational ages 6.5 to 8.5 days (Pijuan-Sala et al., 2019) provided further insights on the association of versican with hemato-endothelial progenitors.
High Vcan expression was first detected in hematoendothelial progenitors emerging at E6.75, as well as in nascent and uncommitted mesoderm ( Fig. 5A-C) . The data showed strong Vcan expression in Kdr-expressing cells (Flk1+ cells) at E6.75, E7.0 and E7.5, spanning mouse gastrulation ( Fig. 5A-C) . Kdr+ cells also expressed Has2, encoding the major embryonic hyaluronan synthase, and the gene encoding a major hyaluronan receptor, CD44 (Fig. 5B ).
These observations further support a cell autonomous role for versican, bound to HA and thus to the cell surface by CD44 and Has2, which forms a membrane channel spooling out HA, and acts as a de facto HA receptor. Notably, since versican is secreted, its expression in the vicinity of cells expressing CD44 or HA could also lead to incorporation into pericellular ECM of the latter. After E7.5, e.g., at E 8.5, Vcan expression is less restricted, occurring in mesoderm, the developing brain, allantois and cardiomyocytes ( Fig. 5A ,C) and Kdr expression extends into endothelial cells. Nevertheless, subsequent hematoendothelial progenitors continue to express Vcan.
Loss of versican dramatically reduces yolk sac and embryo HA levels
In addition to reduced HA in yolk sac blood islands in the absence of versican, we identified a dramatic loss of HAbp staining throughout Vcan Hdf/Hdf embryos (Fig. 6A ). Has2 mRNA expression was unaltered in Vcan Hdf/Hdf embryos and yolk sacs ( Fig. 3F ). Since reduced HAbp staining could result from extraction of unliganded HA from Vcan Hdf/Hdf tissue sections during the staining process, fluorophore-assisted carbohydrate electrophoresis (FACE) (Calabro et al., 2000a; Calabro et al., 2000b; Midura et al., 2018) was undertaken on snap-frozen whole embryos ( Fig. 6B-D) . FACE analysis provided several interesting observations: First, versican is the major CSPG in the E8.5 embryo, contributing nearly all the unsulfated (0S) forms of CS, since both the overall level of CS and its 0S form were dramatically reduced in Vcan Hdf/Hdf embryos (Fig. 6B ). In addition, the data clearly showed reduction of total HA compared to wild type littermates ( Fig. 6C-D) . In combination with unaltered Has2 levels, these findings suggest increased turnover of HA in the absence of versican. Consistent with reduced versican and HA, craniofacial mesenchyme and myocardium were considerably compacted in the absence of versican ( Fig. 6E,F) . We also asked whether the absence of versican affected fibronectin, a major embryonic ECM component that is essential for angiogenesis and observed a dramatic increase both in fibronectin staining and mRNA in Vcan Hdf/Hdf embryos ( Fig. 6G-I 
). Thus, both
Vcan Hdf/Hdf yolk sac and embryo demonstrate a reduction of HA and excess fibronectin.
Embryoid bodies formed by Vcan-null ES cells have impaired angiogenesis and hematopoiesis.
Although these data strongly suggest a local role for a versican-HA pericellular ECM in hematoendothelial progenitors emerging at gastrulation, a lack of hemodynamic forces arising from the cardiac defect in Vcan Hdf/Hdf embryos may influence the dramatic loss of vasculature seen later in embryogenesis (E8.5-9.5). To investigate the role of versican independent of heart development, we used gene editing by CRISPR/Cas9 (Doudna and Charpentier, 2014; Jinek et al., 2012) to introduce Vcan-null mutations in R1 mouse embryonic stem (mES) cells (Nagy et al., 1993) . Vcan exon 2 (containing the start codon) and exon 3 (start of the G1 domain) were targeted independently to obtain mES cell clones D8 and F9 respectively, each with defined frameshift mutations that generate null alleles ( Fig. 7A ). Since exons 2 and 3 are included in all Vcan splice isoforms, no versican was produced, as shown by western blot with anti-GAGβ antibody (Fig. 7B ). The mutated clones retained normal expression of Oct4, Sox2, Nanog and C-myc ( Fig. 7C) indicating their pluripotency was unaffected by Vcan mutagenesis, and validating their suitability for in vitro differentiation. Vcan-null and wild-type ES cells were allowed to dedifferentiate and form embryoid bodies (EBs), in which random differentiation into various lineages occurs. RT-qPCR analysis of Has2 showed no change in Vcan-null EBs (Fig.   S4A ) while the mesoderm differentiation marker Brachyury/T showed a significant decrease in the F9 but not the D8 Vcan-null EBs (Fig. S4B ). Similar to Vcan Hdf/Hdf embryos, Vcan null embryoid bodies showed reduced expression of Flk1 (Fig. S4C ), and the blood lineage commitment markers Itga2b (CD41) and Runx1 (Fig. S4D ), as well as differentiated-blood and vascular endothelial markers (Fig. S4E, F ). Since EB differentiation is random and unaccompanied by formation of a closed circulation, the data strongly suggest that versican acts directly on Flk1+ hematoendothelial progenitors rather than indirectly via its role in cardiac development. In addition, Vcan null EBs demonstrated spontaneous rhythmic contractions suggesting unimpaired differentiation to cardiomyocytes (Supplemental Movie).
To further evaluate the impact on hematoendothelial progenitors, we separately evaluated endothelial and hematopoietic potential. Sprouting angiogenesis was induced by culturing 4-day differentiated EBs in 3-dimensional collagen I gels and treatment with VEGF-A 165 for 12 days (Baker et al., 2012) . Following VEGF stimulation, robust angiogenic sprouting identified by CD31 and smooth muscle α-actin staining was seen in wild-type EBs, but not in the majority of Vcan-null EBs (Fig. 7D,E) . The few Vcan-null EBs with sprouting had fewer sprouts per EB, and these were significantly shorter than wild type sprouts (Fig. 7F,G) . When 10-day old EBs were disaggregated and the cells were plated in a 3-dimensional methylcellulose matrix containing a complete set of blood differentiation cytokines, significantly fewer blood colonies were formed by Vcan null EBs (Fig. 6H ).
Discussion
Although versican is widely expressed during organogenesis and in adult tissues (Bode-Lesniewska et al., 1996) , a notable finding of this work is its specific association with Flk1+ cells from their earliest origin from the mesoderm until establishment of yolk sac vasculature and primitive hematopoiesis. Furthermore, analysis of both Vcan mutant mice in vivo and Vcan-null embryoid bodies in vitro suggest that versican has an essential role in vasculogenesis and primitive hematopoiesis. Taken together, the RNA in situ hybridization data, scRNAseq analysis of Flk1+ cells, and immunostaining of embryos suggests that versican is a product of Flk1+ cells that associates with them via HA and CD44 to form a pericellular matrix. Another major finding of this study is a substantial loss of embryonic and extraembryonic HA in the absence of versican.
As in Vcan Hdf/Hdf yolk sac, avascularity was previously noted in Has2 null yolk sac (Camenisch et al., 2000) , although it was not studied further. Has2 and Vcan null cardiac defects are similar, which suggested that an obligate versican-HA complex in cardiac jelly and endocardial cushions was required for cardiac morphogenesis (Camenisch et al., 2000; Mjaatvedt et al., 1998; Yamamura et al., 1997) . Thus, a versican-HA complex, rather than versican alone, is necessary for vasculogenesis and primitive hematopoiesis, forming a pericellular ECM that constitutes a niche for Flk1+ cells and promotes their survival or differentiation to endothelial and blood cells (Fig. 7) . HA-versican aggregates have a net negative charge, and swelling via absorption of water (the Gibbs-Donnan effect) (Buschmann and Grodzinsky, 1995) . As shown here and previously, tissues compact in their absence (Mjaatvedt et al., 1998; Szabo et al., 2016) . Although versican-deficient yolk sac showed extensive structural disorganization at E9.5, it is clear that the association and effect of versican vis-à-vis Flk1+ cells occurs much earlier, i.e., shortly after gastrulation. Reduced vasculogenesis, angiogenesis and hematopoiesis in embryoid bodies argues also against a secondary effect of a cardiac defect on vasculogenesis, as well as against yolk sac disorganization at E9.5 having a major primary impact on blood island formation. We therefore conclude that versican-HA aggregates act directly and as early as E6.75 within the microenvironment of Flk1+ cells.
Versican and HA form a pericellular matrix in fibroblasts and vascular and myometrial smooth muscle cells (Evanko et al., 1999; Hattori et al., 2011; Mead et al., 2018) which is influential in determining cell phenotype. Specifically, HA, which is extruded from HAS2 complexes in the cell membrane, is decorated with versican and the complex is retained at the cell surface by binding CD44, HAS2 and other receptors (Evanko et al., 2007) . Cd44 is coordinately expressed with Vcan and Has2 in hematoendothelial progenitor cells. Cd44 null mice survive and are not known to have vasculogenesis of primitive erythropoiesis defects (Protin et al., 1999) , suggesting that other HA receptors may participate. The versican-HA pericellular matrix has a well-established impact on different cells. It is anti-adhesive (Evanko et al., 1999; Mead et al., 2018) , which may allow the Flk1+ cells to migrate and proliferate efficiently after their emergence at gastrulation. Another possible role of versican-HA is sequestration of vasculogenic factors such as VEGF-A. Versican binding to VEGF-A via its CSchains (Le Jan et al., 2012) or G3 domain (Zheng et al., 2004) , may generate high concentrations around Flk1+ cells (Fig. S7 ). Versican is associated with Flk1+CD41-cells at their origin, but not with the Flk1-CD41+ yolk sac cells that arise subsequently suggesting that the versican-HA pericellular ECM specifically regulates the fate of Flk1+ cells. We propose that as the dominant CSPG in the embryo, specifically localized to the pericellular ECM of Flk1+ cells, versican may sequester essential trophic factors such as VEGF-A to provide a high local concentration that sustains the Flk1+ population.
Although versican and HA immunostaining (each detecting secreted molecules) strongly labels the blood island ring, their mRNA expression begins in the migratory phase when the progenitor cells first arise from the primitive streak. Alternatively, deposition by neighboring Flk1mesoderm may commence prior to the progenitor cells taking up residence in blood islands.
Because of the dynamic migration of these cells after gastrulation, it may be challenging to ascertain whether the cells move through a versican-HA matrix or carry it with them as an autonomous pericellular matrix. Curiously, and presently unexplained, lack of versican led to more intense Fn1 expression. The observed Vcan-deficient defects are unlikely to result from excess fibronectin, because previous work has shown that deficiency, not excess of fibronectin or the fibronectin receptor subunit α5 integrin results in reduced embryo and yolk sac vascularity (Francis et al., 2002; George et al., 1993) . Taken together with the finding that versican binds fibronectin through the G3 domain (Zheng et al., 2004) , we conclude that the three major components of the provisional embryonic ECM (versican, HA and fibronectin) are each crucial for establishment of the first blood vessels in the embryo. In the absence of versican, the HA catabolism rate likely exceeds the HA anabolism rate since Has2 mRNA levels were relatively unchanged. It was previously noted that HA deposition was reduced to 85% of normal in fibroblasts from a mouse hypomorphic Vcan mutant (Vcan ∆3/∆3 ) with 75% reduction of versican (Suwan et al., 2009) . Accompanying reduced HA deposition, Vcan ∆3/∆3 fibroblasts had accelerated senescence, suggesting a possible mechanism for the lack of Flk1+ cells in Vcan Hdf/Hdf yolk sac.
We found a stronger association of exon 8-containing Vcan transcripts than exon 7containing transcripts with blood islands at gastrulation and exon 7 transcripts were absent at E8.5. Autosomal dominant splice site mutations affecting exon 8 (leading to its exclusion) and exon 8 deletions in humans cause Wagner syndrome (Kloeckener-Gruissem et al., 2006; Kloeckener-Gruissem et al., 2013; Rothschild et al., 2013) , which is characterized by impaired vision and defects of the ocular vitreous and retina, but lacks consistent extra-ocular manifestations. Exon 7 inactivation in mice led to specific neural anomalies and subtle cardiac anomalies (Burns et al., 2014; Dours-Zimmermann et al., 2009 ). Thus, neither individual exon mutation in mice or humans is associated with embryonic lethality, defective vasculogenesis or impaired hematopoiesis. We conclude that both exon 7 and exon 8-containing transcripts, possibly including V0, the transcript containing both exons, are required for vasculogenesis and hematopoiesis.
The GAGβ domain encoded by exon 8 has a unique N-terminal sequence, which is cleaved by ADAMTS proteases at the E 441 -A 442 peptide bond in several contexts, notably cardiac valve development, interdigital web regression, umbilical cord development, neural tube and palate closure and myometrial activation (Mead et al., 2018; Nandadasa et al., 2014; Nandadasa et al., 2015) . The resulting N-terminal versican V1 fragment, G1-DPEAAE 441 , named versikine is bioactive in interdigital web regression and myeloma growth (Hope et al., 2016; McCulloch et al., 2009) . A Vcan knock-in mouse mutant in which E 441 -A 442 was mutated to render it uncleavable has normal yolk sac avascularity (Nandadasa et al., manuscript in preparation) , suggesting that E 441 -A 442 cleavage is not involved in hematovascular development.
In relation to the pro-vasculogenic role of versican-HA complexes, recent work found that syngeneic B16-F10 tumors in adult Vcan Hdf/+ mice had significantly impaired angiogenesis and reduced growth (Asano et al., 2017) . Relevant to the overlap of versican-HA with Flk1 expression, a recent study utilizing the same cancer model in Flk1+/-mice also found reduced angiogenesis during tumor growth (Oladipupo et al., 2018) . Indeed, versican-HA matrix may have a broad role in formation of vasculature in a variety of physiological and disease settings. (A) E8.5 wild type and Vcan Hdf/Hdf yolk sac cross-sections co stained with versican (magenta), HAbp (red) and Flk1 (green). In wild type yolk sac versican-HA staining colocalizes with Flk1. In Vcan Hdf/Hdf yolk sac, blood islands (Bi) are smaller and both HAbp staining and Flk1 staining are weak. The arrowhead shows versican-HA-Flk1 co-stained patches and asterisks mark a cell shown in high magnification in the right-hand panels (N=4 yolk sacs from each genotype). VE, visceral endoderm.
Figures and Figure Legends
(B)
En face confocal imaging of E8.5 yolk sac stained for versican (red) and CD41 (green). The sections were mounted with their mesothelial aspect facing the objective as shown at the bottom. Surface optical sections show versican-rich loci scattered throughout the wild type yolk sac that are absent in Vcan Hdf/Hdf yolk sac. The mid-optical plane shows both versican and CD41 stained cells in blood islands. A patch of versican is associated with each blood island but does not overlap with CD41+ cells. No CD41+ cells were observed in Vcan Hdf/Hdf yolk sac. The high magnification image shows the distinct cell populations marked by versican and CD41. The white arrowheads mark weak CD41 staining of Vcan Hdf/Hdf cells that also lack the rounded morphologies present in the wild-type blood cells (N=3 yolk sacs from each genotype).
(C) Cross section of an E8.5 wild type blood island stained with HAbp (red) and CD41 (green) showing no overlap of HA and CD41+ cells (N=3 yolk sacs).
(D)
Methylcellulose colony forming assay shows significantly fewer blood colony forming units (CFUs) Vcan Hdf/Hdf yolk sacs and embryos (N=3 yolk sacs and three embryos from each genotype, error bars= S.D.,*, p<0.05; **, p<0.001). Note that versican is the major chondroitin sulfate proteoglycan in E8.5 embryos. (Yamamura et al., 1997) were used under a material transfer agreement from Roche. Mouse experiments were conducted with IACUC approval (Protocols 2015 (Protocols :1530 (Protocols and 2018 (Protocols :2045 . Mice were maintained in a fixed light-dark cycle with food and water ad libitum. For genotyping E8.5 embryos with intact yolk sacs, the allantois was dissected out and lysed in 10µl DirectPCR (Tail) digest reagent (Qiagen, supplemented with 1µl of proteinase K overnight at 55°C. A dissected tailpiece was used to genotype E9.5 embryos. Vcan Hdf and wild type alleles were identified with a specific genotyping strategy ( Figure S1 ). Vcan Hdf/Hdf embryos were compared to wild type littermates in all experiments.
Mouse embryonic stem cell (mESC) culture.
R1 mESC (Nagy et al., 1993) were cultured on 0.3% type B gelatin (Sigma-Aldrich, catalog no. G9382) coated 60 mm cell culture plates in Iscove's Modified Dulbecco's Medium (IMDM) Immunostaining of E9.5 and E8.5 yolk sac was carried out on 30µm thick vibratome sections (Nandadasa et al., 2015) or paraffin-embedded 7 µm sections. Immunostaining of collagenembedded embryoid bodies were carried out in 4-chamber cell culture slides (Fisher Scientific, catalog no. 354114) . Confocal microscopy images of whole mount mouse embryos and sections were acquired using a Leica TCS SP5 II multiphoton confocal microscope equipped with a 25X water immersion objective (Leica Microsystems, Wetzlar, Germany). For 3D-projection of whole mount Z-stacks, the Volocity 3D imaging software was used (version 6.3, PerkinElmer, Inc., Waltham, MA) in maximum intensity projection method. Embryoid body formation and induction of vascular sprouts is described in S.I.
Methylcellulose colony formation assay
Single cell suspensions of E8.5 embryos, yolk sacs or day-10 embryoid bodies (EBs) were generated by incubation with trypsin for 10 minutes followed by disaggregation by pipetting with a 200 µL pipette tip until complete. 50,000 cells from each experimental group were transferred to a single 35 mm culture dish containing 1 mL of MethoCult GF M3534 culture medium (Methylcellulose medium with recombinant cytokines for mouse cells, Stem Cell Technologies, Vancouver, CA, catalog no. 03534) using a 3 mL syringe and 16-gauge needle, following the manufacturer's protocol. Triplicate cultures from each genotype were incubated for 14 days in a humidified, 5% CO 2 , 37°C cell culture incubator. Blood colonies were counted using an inverted microscope. Aggregates with >50 cells were considered a colony-forming unit (CFU).
Primary antibodies and dilutions
For staining whole mount embryos, yolk sacs or vibratome sections, the following antibodies, staining reagents and dilutions were used: Rabbit polyclonal anti-mouse versican GAGβ domain (Millipore-Sigma, catalog no. AB1033) 1:200; biotinylated hyaluronan binding protein (HAbp) (Millipore-Sigma, Calbiochem, catalog no. 385911) 1:100; rabbit polyclonal anti-fibronectin (Abcam, catalog no. Ab2413) 1:200; rabbit polyclonal anti-collagen-IV (Rockland antibodies and at 4°C with gentle rocking. LI-COR IR dye secondary antibodies against mouse and rabbit antibodies (LI-COR Biosciences, Lincoln, NE) were used at 1:10000 dilutions in PBS to detect primary antibodies. A LI-COR Odyssey CLx scanner and the LI-COR Image Studio (ver. 4.0) was used to image western blots.
Fluorophore-assisted carbohydrate electrophoresis
FACE procedures used were essentially as previously published (Calabro et al., 2000a; Calabro et al., 2000b; Midura et al., 2018) . In brief, tissue was extensively digested with proteinase K and released glycosaminoglycans (GAGs) were isolated by ice-cold ethanol precipitation and centrifugation. GAGs were resuspended in 0.1 M ammonium acetate, pH 7.0 and then digested overnight with Streptomyces hyaluronidase (200 mU) at 37° C for HA-FACE.
HA digestion products were separated from other intact GAGs using ice-cold ethanol precipitation and centrifugation. The supernatant was then dried under vacuum centrifugation and reacted with 6.25 mM 2-aminoacridone (AMAC) and 625 mM sodium cyanoborohydride (NaBH 3 CN) overnight at 37° C. The pellet was resuspended in 0.1 M ammonium acetate, pH 7.0 and then digested overnight with chondroitinase ABC (25 mU) at 37° C fro CS-FACE. CS digestion products were separated from other intact GAGs using ice-cold ethanol precipitation and centrifugation. The supernatant was then dried under vacuum centrifugation and reacted with 6.25 mM AMAC and 625 mM NaBH 3 CN overnight at 37° C. AMAC-labeled HA and CS digestion products were loaded onto 20% (w/v) acrylamide gels and these products were resolved by electrophoresis at 500 V constant current over a 50-60 minute run time. FACE gels were imaged while still housed in the gel plates on a UVP ChemiDoc-It 2 515 system. Digital gel images were analyzed for AMAC-labeled HA and CS digestion product band intensities using ImageJ (NIH, Bethesda MD).
Transmission electron microscopy
E9.5 yolk sacs were harvested from timed pregnancies and fixed in 4% PFA + 2.5% glutaraldehyde in PBS overnight. Samples were dehydrated in an ethanol:PBS gradient and collagen gel and replaced very 4 days for a further 12 days. The collagen-embedded EBs were washed with PBS and fixed in 4% PFA for 15 min, permeabilized by three washes in PBS containing 0.3% Tween 20 for 30 minutes prior to immunostaining with anti-CD31 or antismooth muscle α-actin (SMA). For qRT-PCR, EBs in floating culture were incubated for 10 days (day-10 EBs). 300 µL of TRIzol reagent (ThermoFisher scientific, catalog no. 15596026) was used to harvest total RNA from each 60 mm plate.
Embryoid body vascular sprout quantifications
For quantifying EB vascular sprouts, collagen-embedded, fixed embryoid bodies in 4-chamber slides were imaged using an inverted bright field microscope. Images were analyzed by Image J-FIJI (NIH, Bethesda, MD), and the freehand drawing tool was used to trace the length of individual vascular sprouts. A total N= 72 wild type, 68 D8 and 68 F9 EBs were analyzed in 3 independent experiments. Lengths of 402 sprouts from wild type, 91 from D8 and 97 from F9 EBs were measured.
